Pharmaco - Press Releases

Date	Title	Company
17-Dec-2020	FDA Approves Amgen's RIABNI(TM) (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)	Amgen
17-Dec-2020	LRA Pleased to Share GSK's Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA	Lupus Research Alliance
17-Dec-2020	FSR Announces Opening of 2020 Fellowship Grant Program	Foundation for Sarcoidosis Research
17-Dec-2020	European Society for Medical Oncology (ESMO) clinical practice guidelines recommend scalp cooling to prevent chemotherapy-induced alopecia	Paxman
17-Dec-2020	Sentinel Capital Partners Provides Junior Capital Financing for Vital Care	Sentinel Capital Partners
17-Dec-2020	Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021	Galmed Pharmaceuticals Ltd.
17-Dec-2020	Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea	Evofem Biosciences, Inc.
17-Dec-2020	Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US	B3C newswire
17-Dec-2020	EVOTEC ACHIEVES KEY MILESTONES IN ITS COLLABORATION WITH BRISTOL MYERS SQUIBB ON TARGETED PROTEIN DEGRADATION	Evotec SE
17-Dec-2020	dMed Completed a US$100 Million Series C Financing	dMed Biopharmaceutical Co., Ltd.
17-Dec-2020	dMed Completed a US$100 Million Series C Financing	dMed Biopharmaceutical Co., Ltd.
17-Dec-2020	Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange	和铂医药
16-Dec-2020	Conference Chair from Johnson & Johnson invites you to attend Pre-filled Syringes East Coast 2021	SMi Group Ltd
16-Dec-2020	Exclusive Interview: Julian Bahr, Postdoctoral Fellow at AstraZeneca and speaker at 3D Cell Culture Conference	SMi Group
16-Dec-2020	Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform	Abbott
16-Dec-2020	Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities	Sygnature Discovery
16-Dec-2020	Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2	B3C newswire
16-Dec-2020	Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development	Grünenthal Group
16-Dec-2020	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. new Home Member State	Vivoryon Therapeutics N.V.
16-Dec-2020	Precigen Provides Latest Clinical Developments at Virtual R&D Update Event	Precigen, Inc.